Crossmark Global Holdings’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.46M | Buy |
15,570
+12,968
| +498% | +$2.36M | 0.04% | 324 |
|
|
2026
Q1 | $400K | Sell |
2,602
-22,564
| -90% | -$3.06M | 0.01% | 912 |
|
|
2025
Q4 | $2.86M | Sell |
25,166
-5,324
| -17% | -$647K | 0.04% | 354 |
|
|
2025
Q3 | $4.05M | Sell |
30,490
-6,107
| -17% | -$839K | 0.06% | 282 |
|
|
2025
Q2 | $5.21M | Sell |
36,597
-172
| -0.5% | -$24.4K | 0.08% | 244 |
|
|
2025
Q1 | $5.62M | Buy |
36,769
+6,000
| +20% | +$943K | 0.1% | 224 |
|
|
2024
Q4 | $4.6M | Buy |
30,769
+4,942
| +19% | +$775K | 0.08% | 240 |
|
|
2024
Q3 | $4.23M | Buy |
25,827
+6,896
| +36% | +$1.02M | 0.08% | 264 |
|
|
2024
Q2 | $2.62M | Buy |
18,931
+260
| +1% | +$35.8K | 0.05% | 341 |
|
|
2024
Q1 | $2.58M | Buy |
18,671
+1,171
| +7% | +$140K | 0.05% | 359 |
|
|
2023
Q4 | $1.83M | Sell |
17,500
-5,631
| -24% | -$520K | 0.04% | 421 |
|
|
2023
Q3 | $2.11M | Buy |
23,131
+2,791
| +14% | +$285K | 0.05% | 379 |
|
|
2023
Q2 | $2.06M | Buy |
20,340
+8,732
| +75% | +$810K | 0.04% | 409 |
|
|
2023
Q1 | $941K | Buy |
11,608
+4,564
| +65% | +$366K | 0.02% | 602 |
|
|
2022
Q4 | $526K | Buy |
7,044
+925
| +15% | +$71.8K | 0.01% | 777 |
|
|
2022
Q3 | $507K | Sell |
6,119
-2,530
| -29% | -$222K | 0.01% | 770 |
|
|
2022
Q2 | $692K | Buy |
8,649
+2,410
| +39% | +$244K | 0.02% | 687 |
|
|
2022
Q1 | $705K | Sell |
6,239
-3,610
| -37% | -$405K | 0.02% | 764 |
|
|
2021
Q4 | $1.12M | Sell |
9,849
-11,760
| -54% | -$1.26M | 0.02% | 594 |
|
|
2021
Q3 | $2.51M | Sell |
21,609
-1,640
| -7% | -$205K | 0.06% | 327 |
|
|
2021
Q2 | $2.8M | Sell |
23,249
-1,670
| -7% | -$198K | 0.07% | 291 |
|
|
2021
Q1 | $2.69M | Sell |
24,919
-3,460
| -12% | -$384K | 0.07% | 297 |
|
|
2020
Q4 | $3.33M | Buy |
28,379
+20,000
| +239% | +$2.04M | 0.08% | 264 |
|
|
2020
Q3 | $718K | Sell |
8,379
-1,000
| -11% | -$85.4K | 0.02% | 636 |
|
|
2020
Q2 | $742K | Sell |
9,379
-409
| -4% | -$31.9K | 0.02% | 625 |
|
|
2020
Q1 | $744K | Sell |
9,788
-578
| -6% | -$45.4K | 0.03% | 547 |
|
|
2019
Q4 | $778K | Sell |
10,366
-18,023
| -63% | -$1.2M | 0.02% | 632 |
|
|
2019
Q3 | $1.62M | Sell |
28,389
-1,199
| -4% | -$69.7K | 0.05% | 416 |
|
|
2019
Q2 | $1.67M | Sell |
29,588
-1,790
| -6% | -$92.7K | 0.05% | 438 |
|
|
2019
Q1 | $1.7M | Buy |
31,378
+10
| +0% | +$553 | 0.05% | 421 |
|
|
2018
Q4 | $1.61M | Buy |
31,368
+9,073
| +41% | +$581K | 0.05% | 410 |
|
|
2018
Q3 | $1.6M | Sell |
22,295
-710
| -3% | -$50.2K | 0.04% | 473 |
|
|
2018
Q2 | $1.6M | Sell |
23,005
-140
| -0.6% | -$9.35K | 0.04% | 459 |
|
|
2018
Q1 | $1.53M | Sell |
23,145
-2,018
| -8% | -$148K | 0.04% | 489 |
|
|
2017
Q4 | $1.82M | Buy |
25,163
+1,650
| +7% | +$102K | 0.04% | 455 |
|
|
2017
Q3 | $1.4M | Buy |
+23,513
| New | +$1.42M | 0.04% | 510 |
|
|
2016
Q3 | $1.4M | Buy |
+23,513
| New | +$1.66M | 0.04% | 510 |
|
Other funds holding DVA
WCM
PFS
GIA
SC
CMF
CAMG
Crossmark Global Holdings's DVA Position: Q2 2026 in Review
Crossmark Global Holdings increased its DaVita (DVA) stake by 498% in Q2 2026, buying an estimated $2.36M and bringing the position to 15,570 shares worth $3.46M. The position accounts for 0.04% of the portfolio, ranked #324.
Crossmark Global Holdings first reported a position in DVA in Q3 2016 and has held it in 37 quarters since. The position peaked at $5.62M in Q1 2025. 87 funds tracked by Wall St. Rank hold DVA as of Q2 2026.
- Crossmark Global Holdings held 15,570 shares of DaVita worth $3.46M as of Q2 2026.
- Crossmark Global Holdings bought 12,968 DaVita shares in Q2 2026, an estimated $2.36M.
- DaVita made up 0.04% of Crossmark Global Holdings's portfolio in Q2 2026, its #324 holding.
- Crossmark Global Holdings first reported a position in DaVita in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's DaVita position peaked at $5.62M in Q1 2025.
- 87 funds tracked by Wall St. Rank held DaVita as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.